Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
1.790
+0.030 (1.70%)
At close: Aug 14, 2026, 4:00 PM EDT
1.790
0.00 (0.01%)
After-hours: Aug 14, 2026, 7:59 PM EDT

Organogenesis Holdings Revenue

Organogenesis Holdings had revenue of $43.76M in the quarter ending June 30, 2026, a decrease of -56.68%. This brings the company's revenue in the last twelve months to $457.45M, up 6.50% year-over-year. In the year 2025, Organogenesis Holdings had annual revenue of $564.17M with 17.04% growth.

Revenue (ttm)
$457.45M
Revenue Growth
+6.50%
P/S Ratio
0.50
Revenue / Employee
$535,660
Employees
854
Market Cap
230.33M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025564.17M82.13M17.04%
Dec 31, 2024482.04M48.90M11.29%
Dec 31, 2023433.14M-17.75M-3.94%
Dec 31, 2022450.89M-16.47M-3.52%
Dec 31, 2021467.36M129.06M38.15%
Dec 31, 2020338.30M77.32M29.63%
Dec 31, 2019260.98M67.53M34.91%
Dec 31, 2018193.45M-5.06M-2.55%
Dec 31, 2017198.51M59.78M43.09%
Dec 31, 2016138.73M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.